KDR and neoplasm: Of these, VEGFR multikinase inhibitors exhibit their effects on VEGFR, PDGFR, and FGFRs, among other members of the VEGFR family, and have demonstrated robust inhibition of angiogenesis in the tumor microenvironment leading to clinical success in many solid tumors (9, 34).